Breakfast symposium 1 Sponsored by Huons Chair(s): Yong-Wook Cho
Thursday 10 October, 08:00~08:40
Room 3

BS1
Sang-Man JinSungkyunkwan University, Korea

Smart insulin pen: less burden, clear benefit

Breakfast symposium 2 Sponsored by Hanmi Pharmaceutical Chair(s): Kyung Mook Choi
Thursday 10 October, 08:00~08:40
Room 4

BS2
Yongin ChoInha University, Korea

It's time to break therapeutic inertia in dyslipidemia treatment

Breakfast symposium 3 Sponsored by Jin Yang Pharm Chair(s): Jeung Hun Han
Friday 11 October, 08:00~08:40
Room 3

BS3
Jin YuThe Catholic University of Korea, Korea

Effectiveness of sulfonylurea and SGLT2 inhibitor combine therapy

Breakfast symposium 4 Sponsored by Ildong Pharmaceutical Chair(s): Kwan Woo Lee
Friday 11 October, 08:00~08:40
Room 4

BS4
Chang Hee JungUniversity of Ulsan, Korea

SGLT2 inhibitor + DPP4 inhibitor combination therapy efficacy, safety and patients compliance

Breakfast symposium 5 Sponsored by GSK Chair(s): Sei Hyun Baik
Friday 11 October, 08:00~08:40
Room 5

Eun-Jung RheeSungkyunkwan University, Korea

Why is Shingrix vaccination necessary for patients with diabetes mellitus?

Luncheon symposium 1 Sponsored by AstraZeneca Chair(s): Jae Myung Yu
Thursday 10 October, 11:30~11:45
Room 1

LS1
Roger ChenSt Vincent’s Hospital, Australia

What is the therapy with balanced efficacy and safety for T2D?

Luncheon symposium 2 Sponsored by Viatris Chair(s): In-Kyu Lee
Thursday 10 October, 11:30~11:45
Room 2

LS2
A Ram Hong Chonnam National University, Korea

Patients in dyslipidemia accompanied by diabetes: concerns about kidney, the silent organ

Luncheon symposium 3 Sponsored by Celltrion Chair(s): Ho-Cheol Kang
Thursday 10 October, 11:30~11:45
Room 3

LS3
Joon Ho MoonSeoul National University, Korea

Reappraisal of TZD to control diabetes and its complications

Luncheon symposium 4 Sponsored by Sanofi Chair(s): Kyung Ah Han
Thursday 10 October, 11:30~11:45
Room 4

LS4
So Hun KimInha University, Korea

Importance of timely insulinization and intensification for optimal diabetes management

Luncheon symposium 5 Sponsored by JW Pharmaceutical Chair(s): Jae Myung Yu
Thursday 10 October, 11:45~12:00
Room 1

LS5
Su Jin JeongSejong General Hospital, Korea

Management of inadequately controlled patients with diabetes mellitus

Luncheon symposium 6 Sponsored by Lilly Chair(s): In-Kyu Lee
Thursday 10 October, 11:45~12:00
Room 2

LS6
Young Min ChoSeoul National University, Korea

The first GIP and GLP-1 receptor agonist for T2D treatment

Luncheon symposium 7 Sponsored by Yuhan Chair(s): Ho-Cheol Kang
Thursday 10 October, 11:45~12:00
Room 3

LS7
Young Sang LyuChosun University, Korea

Connecting the dots along the cardio-renal-metabolic disease continuum

Luncheon symposium 8 Sponsored by Yooyoung Chair(s): Kyung Ah Han
Thursday 10 October, 11:45~12:00
Room 4

LS8
Sangyong KimChosun University, Korea

Revalued combination therapy for T2DM patients

Luncheon symposium 9 Sponsored by Bayer Chair(s): Hyoungwoo Lee
Friday 11 October, 12:50~13:05
Room 1

LS9
Kyu Yeon HurSungkyunkwan University, Korea

Latest advancement in chronic kidney disease with type 2 diabetes treatment: non-steroidal MRA

Luncheon symposium 10 Sponsored by BI-LLY Chair(s): Kyungwan Min
Friday 11 October, 12:50~13:05
Room 2

LS10
Jong Han ChoiKonkuk University, Korea

Empagliflozin at the heart of changing diabetes treatment guidelines

Luncheon symposium 11 Sponsored by Daewoong Pharmaceutical Chair(s): In Joo Kim
Friday 11 October, 12:50~13:05
Room 3

LS11
Dughyun ChoiSoonchunhyang University, Korea

Optimal combination therapy for diabetes management based on renal function

Luncheon symposium 12 Sponsored by Handok Chair(s): Kyong Soo Park
Friday 11 October, 12:50~13:05
Room 4

LS12
Seung-Hwan LeeThe Catholic University of Korea, Korea

CGM: a game-changer in diabetes care - evidence, impact, and future directions

Luncheon symposium 13 Sponsored by Chongkundang Chair(s): Hyoungwoo Lee
Friday 11 October, 13:05~13:20
Room 1

LS13
Eun Young LeeThe Catholic University of Korea, Korea

Novel insights into combination therapy: SGTL2I+DPP4I in patients with T2DM

Luncheon symposium 14 Sponsored by Dong-A ST Chair(s): Kyungwan Min
Friday 11 October, 13:05~13:20
Room 2

LS14
Gyuri KimSungkyunkwan University, Korea

Initial combination therapy in type 2 diabetes management

Luncheon symposium 15 Sponsored by LG Chem Chair(s): In Joo Kim
Friday 11 October, 13:05~13:20
Room 3

LS15
Joonyub LeeThe Catholic University of Korea, Korea

The latest research on gemigliptin and its role in treating diabetes in the elderly

Luncheon symposium 16 Sponsored by Novo Nordisk Chair(s): Kyong Soo Park
Friday 11 October, 13:05~13:20
Room 4

LS16
Bo Kyung KooSeoul National University, Korea

Exploring potential solutions for optimal glycemic control: role of FRC and digital healthcare solutions